F2RL1 and Alzheimer disease: Steinhoff et al. (120) reported an increased signaling through PAR-2 that comprises an increased release of endogenous PAR-2 agonist mast cell tryptase followed by a higher occurrence of PAR-2+ nerve fibers in AD patients (120, 133).